Summary. The neuropeptides vasopressin and oxytocin were first characterized as hormones, i. e., signalling molecules which are synthesized in hypothalamic neurones, transported toward the neurohypophysis and from there secreted into the general circulation. Although extrahypophysial Gomori-positive pathways were described in the brain as early as the mid-1950s, it is only during the last decade that the neurotransmitter role of vasopressin and oxytocin has begun to be investigated. Recent electrophysiological and morphological studies from our laboratory are summarized. Using extracellular and intracellular recordings from in vitro brain slices, a direct excitatory action of vasopressin was demonstrated in the lateral septum and in the nucleus of the solitary tract. This action of vasopressin was mediated by V1-type receptors. An excitatory effect of oxytocin, mediated by receptors similar to those present in uterus, has also been found in the dorsal motor nucleus of the vagus nerve. In accordance with these results, light microscopic autoradiography showed the presence in these brain areas of high affinity binding sites for vasopressin and for oxytocin, respectively. While these data corroborate the notion that vasopressin and oxytocin are probably involved in interneuronal communications, several questions, however, remain. The membrane mechanism by which vasopressin and oxytocin cause neuronal excitation is still unknown and evidence that endogenous vasopressin and oxytocin act at central synapses deserves further investigation.
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"Neurosecretory"
and "neuroendocrine" are adjectives coined to specify a particular type of cells in the vertebrate brain which have a dual nature: neural and endocrine. The most studied endocrine neurones are the hypothalamo-neurohypophysial cells which produce and secrete the neurohormones oxytocin and vasopressin.
Biosynthesis of vasopressin and oxytocin takes place in the perikarya of separate oxytocin-and vasopressin-producing neurones. From the endoplasmic recticulum, the prohormones make their way to the Golgi apparatus and are then packaged into secretory granules. During axonal transport of the granules, the prohormones are enzymatically cleaved to yield vasopressin or oxytocin. These compounds are released into the circulation from the nerve endings in the posterior pituitary when the latter are depolarized by incoming action potentials. Carried in the general circulation, they reach those targets on which they exert their biological actions: a rise in arterial blood pressure and a reduction of urine output (for vasopressin), as well as uterine contractions at the end of pregnancy and stimulation of milk-ejection during suckling (for oxytocin).
The establishment in the early fifties of formulas for these hormones and their full synthesis represented a major achievement for which DU VIGNEAUD (1956) was awarded the Nobel Prize in Chemistry. A great number of structural analogues have since been synthesized.
The relative potency of some vasopressin analogues in raising blood pressure does not parallel their antidiuretic efficacy. It appeared therefore that vasopressin might exert its effects by interacting with more than one type of receptors. Moreover, while the antidiuretic effect of vasopressin is associated with an accumulation of cyclic AMP in the renal tubular cells, other effects of vasopressin are linked to an increase in membrane phosphatidylinositol turnover and in intracellular free calcium. It is now assumed that vasopressin exerts some of its effects by binding to a V, receptor whose intracellular signal is carried by calcium, whereas the antidiuretic effect would result from binding to a V2 receptor linked to an adenylate cyclase. This view has been corroborated by studies on the binding of tritiated vasopressin to cells in the kidney, liver and vascular smooth muscle.
High affinity binding sites for tritiated oxytocin were demonstrated in the uterus and in mammary glands, half-maximal binding being achieved at concentrations in the nanomolar range. Binding sites for oxytocin are specific and differ from V1 and V2. Structural analogues of oxytocin exist which compete with tritiated oxytocin in proportion to their uterotonic activity.
The finding that vasopressin and oxytocin were secreted but not manufactured within the pituitary gland and that the secretions were produced in the hypothalamus and then transported to the pituitary for storage and release relied heavily upon the successful impregnation of the entire hypothalamoneurohypophysial system with Gomori's stain and the demonstration of an accumulation of secretory product in the hypothalamic stump of the sectioned pituitary stalk.
Although oxytocin and vasopressin were the first neuropeptides to be structurally characterized and synthetized, it is only recently that their role as neurotransmitters has been investigated. The existence of additional, extrahypophysial Gomori-positive pathways in the brain was actually suspected in the 1950s. Moreover, Barry demonstrated that in the target fields of these extrahypophysial pathways, Gomori-positive terminals make close contact with neuronal cell bodies, and therefore proposed that neurohypophysial peptides might act at these "neurosecretory synapses" as transmitters (DREIFUSS, 1988) . Decades later immunoelectron microscopy confirmed the existence of vasopressin-or oxytocin-containing synapses. In the limbic system and in the dorsal brainstem of rats, BUIJS and SWAAB (1979) and VOORN and BUIjs (1983) observed presynaptic structures containing vesicles that had reacted with antibodies directed against oxytocin or vasopressin. The synaptic contacts were mostly axodendritic and the vesicles were 80-100 nm in diameter. At about the same time, BUIJS and VAN HEERIKHUIZE (1982) were studying the release of vasopressin and oxytocin from brain slices and showed that their rate of secretion significantly increased following depolarization with potassium or veratridine.
Our group has provided data which strongly support a neurotransmitter role for vasopressin and oxytocin. We have combined morphological and electrophysiological approaches. Thus, the presence in the brain of vasopressin and oxytocin has been ascertained by immunohistochemistry (DUBOIS-DAUPHIN and ZAKARIAN, 1987) ; the distribution of vasopressin and oxytocin binding sites has been examined by light microscopic autoradiography (TRIBOLLET et al., 1988a, b) . Functional studies have been carried out using extracellular or intracellular recordings from in vitro brain slices DREIFUSS et al., 1988; MUH-LETHALER et al., 1982 ,1983 RAGGENBASS et al., 1987a RAGGENBASS et al., , b,1988 RAGGENBASS et al., 1989 and from a sympathetic ganglion (KIRALY et al., 1986) . Early results have been reviewed elsewhere (MUHLETHALER et al., 1985) . Below we summarize some more recent electrophysiological findings and relate them to data obtained by mapping the distribution of binding sites for vasopressin and oxytocin in the brain.
VASOPRESSIN EFFECT IN THE LATERAL SEPTUM
In rats, the lateral division of the septum is densely innervated by vasopressin-immunoreactive fibres and terminals. Most of these fibres probably originate-in the bed nucleus of the stria terminalis and in the amygdala (CAFFE et al., 1987) . Vasopressin can be released in vitro from rat septal slices in a calciumdependent manner (BUIJS and VAN HEERIKHUIZE, 1982) . In addition, binding sites for vasopressin have been detected in the rat septum (POULIN et al., 1988; SHEWEY and DORSA, 1988) . These data suggest that vasopressin may function as a neurotransmitter in the lateral septum. Electrophysiological data obtained on septal neurones corroborate this conjecture.
We have carried out single-unit recordings from slices of the rat brain and have examined the effects of known concentrations of vasopressin on the excitability of neurons located in the lateral septum (RAGGENBASS et al., 1987b . Stable recordings were obtained from over one hundred neurons located in the dorsal and intermediate areas of the lateral septum. They were either silent or fired irregularly. Vasopressin, at concentrations ranging from 1 nM to 1 pM, excited approximately half of the neurones; most of the remaining neurones did not respond and a very few were inhibited. The vasopressin-induced excitation was concentration-dependent and fully reversible.
In preliminary experiments, intracellular recordings were carried out from neurons located in the lateral septum. Only a few of the impaled neurones responded to vasopressin, compared with the much higher percentage of responsive neurones when extracellular recordings were sought. In responsive neurones, the vasopressin-induced increase in firing was clearly associated with membrane depolarization ( Fig. 1) To ascertain that the electrophysiological action of vasopressin was receptor-mediated, we tested the effects of synthetic structural analogues acting as antagonists. When tested in the lateral septum, these compounds did not affect firing per se, but fully suppressed the excitatory effect of vasopressin (Fig.  2) . Following the washout of the antagonist, the responsiveness to vasopressin slowly recovered to full strength.
Lateral septal neurones responsive to vasopressin were also tested for oxytocin sensitivity: all wer efound to respond. However, oxytocin was 10-200 times less potent than vasopressin and none was excited by a selective oxytocic agonist even when applied at micromolar concentrations. Thus, in nearly all septal neurones tested, the excitation brought about by oxytocin was due to an interaction of this peptide with vasopressin receptors rather than with oxytocin receptors. The type of receptors mediating the excitatory effect of vasopressin in the lateral septum was ascertained by testing the action of the vi agonist, [Phe2, Orn8] VT, and of the V2 selective agonist, dDAVP, on vasopressin-responsive neurones. While none responded to the V2 agonist, even when it was added to the perifusion solution at high concentration, all were excited by the V1 agonist. The data show that the predominant effect of vasopressin on neurones located in the lateral septum of rats is excitatory; moreover, they indicate that this action is mediated by V1 vasopressin receptors. Autoradio- Fig, 1 . Effects of vasopressin (AVP) on the frequency of discharge and on the membrane potential of a lateral septal neurone. AVP was added for the duration is indicated by horizontal lines and at the concentrations indicated. The first and third traces are ratemeter records of firing; the second and fourth traces are intracellular recordings (the spike amplitude is reduced because of the low frequency response of the chart recorder). Note that the vasopressin-induced increase in firing rate was concentration-dependent and was accompanied by a membrane depolarization. AVP 10-6 M AVP 10-7 M graphic data from our laboratory were in accordance with these results (RAGGENBASS et al., 1987b; TRIBOLLET et al., 1988a tract and the dorsal motor nucleus of the vagus nerve (SOFRONIEW, 1985; DUBOIS-DAUPHIN and ZAKARIAN, 1987) and, using immunoelectron microscopy, oxytocin-containing and vasopressin-containing nerve terminals have been shown to form synapses on solitary tract neurones (BUIJS et al.,1985; VOORN and BUIJS, 1983) . Vasopressin and oxytocin can be released in vitro, in a calcium-dependent manner, from brainstem slices containing the nucleus of the solitary tract (BUIJS and VAN HEERIKHUIZE,1982) . In addition, this nucleus contains a high amount of vasopressin binding sites (TRIBOLLET et al., 1988a, b) .
In order to test whether exogenous vasopressin may influence the bioelectrical activity of neurones located in the nucleus of the solitary tract, we carried out single-unit extracellular recordings from brainstem slices of the rat. The recording micropipette was positioned in the slice with the help of a dissection microscope. A translucent region encompassed in a dorso-ventral direction the nucleus of the solitary tract, the dorsal motor nucleus of the vagus nerve and the hypoglossal nucleus and could be easily differentiated from the surrounding whitish brainstem tissue.
Among 120 solitary tract neurones, about 45% responded to vasopressin dissolved in the perifusion solution by a reversible increase in firing (Fig. 3, first  trace) . The remaining neurones were unaffected. The effect of vasopressin on the sensitive neurones was concentration-dependent.
The lowest vasopressin concentration effective in evoking an excitation was 5 nM; micromolar concentrations of vasopressin evoked maximal or nearly maximal effects.
The effect of vasopressin was postsynaptic, rather [Phe27Orn8]VT 10-6M than presynaptic, since it persisted when the preparation was perifused in a low-calcium, high-magnesium solution previously shown to block synaptic transmission in the dorsal medulla (RAGGENBASS et al., 1987a) . The vasopressin-induced neuronal excitation was suppressed by an antivasopressor antagonist, indicating that it was receptor mediated. Oxytocin was 20-100 times less potent than vasopressin and a selective oxytocic agonist was without effect. A potent, selective antidiuretic agonist had no effect (Fig. 3, second  trace) . By contrast, a vasopressor agonist was nearly as potent as vasopressin in evoking neuronal excitation (Fig. 3, third trace) . We conclude that a subclass of solitary tract neurones possess functional vasopressin receptors of the V1 type, whose activation leads to an increase in their bioelectrical activity.
OXYTOCIN EFFECT IN THE DORSAL MOTOR NUCLEUS OF THE VAGUS NERVE
The vagal complex receives an oxytocinergic innervation originating from the paraventricular nucleus of the hypothalamus.
Some years ago, our group showed that individual neurones in the dorsal motor nucleus in the rat respond to vasopressin and oxytocin by an increase in firing. Pharmacological studies in which we used synthetic structural analogues with known affinities for peripheral receptors indicated that the excitation of vagal neurones was probably mediated by oxytocin receptors .
In an earlier study, we used as an antagonist a compound which acts both as an antioxytocic and as an antivasopressor.
In the meantime, new derivatives of ornithine-oxytocin have become available which are much more specific antagonists of oxytocin than any other previously known. The new antagonist applied at 20 to 50 nM completely (Fig. 4 , third trace) or nearly completely suppressed the excitation brought about by oxytocin. When tested at higher concentrations, the antagonist had an almost irreversible effect, whereas at 20 to 50 nM, the response to oxytocin could be partially recovered (Fig. 4, lowest  trace) .
Since the oxytocin antagonist effectively blocked oxytocin effects in the dorsal motor nucleus of the vagus nerve, we concluded that vagal motoneurones probably bear oxytocin receptors. Direct evidence for this contention was obtained using a 125I-labelled oxytocin antagonist in light microscopic autoradiographical studies (ELANDS et al., 1988) . Binding sites could be detected in the rat brainstem, particularly in the dorsal motor nucleus of the vagus nerve .
GENERAL REMARKS
In order to be identified as a neurotransmitter in the central nervous system, a substance should fulfil several criteria, among which are the following: 1) it must be present in axons and axons terminals in selected areas of the brain; 2) specific neuronal receptors should exist which interact with this substance; and 3) the binding of the substance to these receptors should induce changes in membrane permeability leading to neuronal excitation or inhibition. In recent years, work in our laboratory has concentrated on the question of whether vasopressin and oxytocin satisfy such requirements, and we have combined morphological and electrophysiological approaches. First data gathered from autoradiographical studies will be discussed.
High affinity binding sites for tritiated vasopressin have been found in the limbic system (lateral septum, amygdala), in the hypothalamus (suprachiasmatic nucleus) and in the brainstem, including the nucleus of the solitary tract (Fig. 5A ). Displacement studies, carried out using various receptor-specific agonists, showed that these sites are similar, if not identical, to the V1 vasopressin receptors present on vascular smooth muscle cells and on hepatocytes. High affinity binding sites for tritiated oxytocin were detected in the olfactory tubercule, in the hypothalamus (ventromedial nucleus), in the amygdala and in the ventral hippocampus. Using a radioidinated oxytocin antagonist, additional oxytocin binding sites were detected in the brainstem (Fig. 5B) . Little overlap in the distribution of vasopressin and oxytocin binding sites could be evidenced.
Although the presence of vasopressin and oxytocin binding sites in the brain suggested that these peptides may play a role in interneuronal communication, alternative interpretations must be considered. Thus, binding sites may be located on nonneuronal cells (such as glial or endothelial cells) or may not represent functional neuronal receptors. If they do, they may correspond to neuronal receptors whose activation generates or modulates cellular processes not involved in neuronal signalling. It was thus essential to assess whether the presence of vasopressin or oxytocin binding sites in a given brain area correlated with the existence, in this same area, of a neuronal sensitivity to these peptides. Electrophysiological studies reviewed in the present article and carried out OT 2-10-7M
OT 2-10-7M from selected brain areas suggest that such a correlation exists. A substantial fraction of lateral septal neurones and solitary tract neurones were found to be responsive to vasopressin. By contrast, vagal motoneurones responded to oxytocin. In all cases the action of these peptides was excitatory and direct, and took place at nanomolar to micromolar concentrations.
We conclude that: 1) central high affinity binding sites for vasopressin and oxytocin, or part of them, represent functional neuronal receptors; and 2) that the interaction between these peptides and their receptors does lead to bioelectrical signalling. Thus, vasopressin and oxytocin belong to the category of peptides which on the one hand act as hormones, but on the other probably also function as neurotransmitters/neuromodulators in the central nervous system. As stated above, immunohistochemical studies played a major role in the genesis of the notion that vasopressin and oxytocin are involved in interneuronal communication.
However, when the data from immunohistochemistry were compared with those from electrophysiology and autoradiography, some unexpected discrepancies appeared. For instance, oxytocin-sensitive neurones are present in the vagal nucleus and in the ventral hippocampus, where only few oxytocin-containing axons could be evidenced by immunocytochemistry.
There are several reasons why immunohistochemistry may not always constitute the most adequate approach in demonstrating the presence, in a given area, of a functional neurotransmitter: 1) Neuropeptides may be shed at a distance from their site of action, particularly those which exert slow and prolonged effects. 2) Due to the balance between synthesis, storage and release, a transmitter may be present, at any given time, only in minute quantities and immunohistochemistry may fail to reveal it in axons and axon terminals. On the other hand, if release is low with respect to synthesis and/or storage-or if release is not taking place at all -a releatively high amount of immunoreactivity might be detected whose functional significance would be dubious.
Although on track, the demonstration that vasopressin and oxytocin are neurotransmitters if far from being complete. One point which deserves more investigation concerns the membrane mechanism by which these peptides cause neuronal excitation. Intracellular recordings from vagal motoneurones and from lateral septal neurones indicate that the increase in firing induced by oxytocin or by vasopressin is usually associated with postsynaptic membrane depolarization.
It is reasonable to postulate that these peptides may act by increasing or by decreasing the membrane permeability to ions whose equilibrium potentials are, respectively, more positive or more negative than the resting membrane potential -although an influence on electrogenic ionic pump(s)
cannot, at present, be excluded. Because they can be stably impaled, vagal motoneurones should provide an adequate model for studying the membrane mechanism of the neuronal action of oxytocin, provided the peptide-induced changes in permeability are strong enough and take place at the level, or in the vicinity, of the cell body.
Another major aim for future research will be to show whether endogenous vasopressin and oxytocin are involved in the normal functioning of the brain. A clue to a possible interpretation of the oxytocin present in the dorsal motor nucleus of the rat vagus nerve has been provided by RoGERs and HERMANN (1985) . These authors showed that oxytocin injected into the dorsal motor nucleus of the vagus nerve evokes an increase in gastric acid secretion and a reduction in heart rate, effects comparable to those observed following stimulation of the vagus nerve or its nucleus of origin. These parasympathomimetic effects of oxytocin on the stomach and heart could be prevented by prior microinjection of oxytocin antagonist into the dorsal brainstem. ROGERS and HERMANN (1986) also demonstrated that the increase in gastric acid secretion and the bradycardia induced by electrical stimulation of the paraventricular nucleus of the hypothalamus could be antagonized by microinjection of oxytocin antagonist into the dorsal motor nucleus of the vagus nerve. By providing evidence for a role of endogenous oxytocin on neurones located in the dorsal motor nucleus of the vagus nerve, these experiments strongly support the view that oxytocin can modulate autonomic functions by a central action (SAWCHENKO and SWANSON, 1985) .
Vasopressin and oxytocin are synthesized in, transported within, and secreted from, two distinct classes of central neurones: 1) hypothalamo-neurohypophysial neurones and 2) neurones which project toward various areas of the brain and spinal cord. Accordingly, vasopressin and oxytocin act as hormones-a well established fact-and as neurotransmitters-for which there is accumulating evidence.
In addition, oxytocin has been recently shown to be produced in and secreted from the ovary. In particular, there is a large surge of luteal oxytocin production upon ovulation in cows and sheep (IvELL and RICHTER, 1984) . Ovarian oxytocin is thought to cause luteolysis by stimulating, via the hydrolysis of phosphoinositides, the production of a luteolytic prostaglandin in the ovine and bovine endometrium (FLINT et al., 1986) . Thus, cells which belong to different functional subdivisions of the organism use one and the same peptide as a messenger molecule. Whether this reflects some kind of evolutionary accident or, rather, is due to the fact that these cells subserve a general, integrative function is not yet known.
